ABVC earnings at a glance
ABVC Biopharma, Inc. (ABVC) is scheduled to report earnings on Friday, October 30, 2026 — in 7 days. The options market is pricing a move of about ±476.6% after the report, a range of roughly -$3.99 to $6.11 from today's $1.06. Over its last 4 reports the stock rose the next day 2 times and fell 2, moving ±3.2% on average; after the most recent report on May 18, 2026 it moved -1.8%. That means options currently expect more movement than ABVC has typically delivered. Implied volatility is currently 28%. The share price of $1.06 sits near its 52-week low.
Overview
Earnings trends
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.03 | — | — | — | — | financials |
| Mon May 18, 2026 | Mar/2026 | $-0.06 | — | — | 0.0% | -1.8% | earnings |
| Fri Oct 31, 2025 | Sep/2025 | $-0.05 | — | — | — | +5.7% | earnings |
| Wed Aug 13, 2025 | Jun/2025 | $-0.13 | — | — | — | +2.4% | earnings |
| Wed Apr 30, 2025 | Mar/2025 | $-0.06 | — | — | — | -2.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.03 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.08 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.29 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.82 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.68 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Fri Oct 30, 2026 | Sep/2026 | OTHER | — | -$0.05 |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $795,950 | — | — | — | $389,276 |
| Cost of revenue | — | — | — | — | — | — | — | $296 |
| Gross profit | — | — | — | $795,950 | — | — | — | $388,980 |
| Operating income | $-779,526 | $-2M | — | $-2M | $-2M | $-693,005 | — | $-302,316 |
| Net income | $-736,934 | $-2M | — | $-2M | $-2M | $-842,075 | — | $-394,769 |
| EPS (diluted) | $-0.03 | $-0.06 | — | $-0.09 | $-0.13 | $-0.06 | — | $-0.03 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $31,944 | $140,324 | $681,480 | $192,068 | $388,251 | $152,206 | $248,382 | $137,344 |
| Inventory | — | — | — | $11,460 | $11,460 | $11,460 | — | — |
| Total current assets | $411,729 | $648,848 | $3M | $3M | $3M | $1M | $2M | $2M |
| Total assets | $19M | $20M | $21M | $21M | $16M | $15M | $8M | $8M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $7M | $7M | $8M | $7M | $7M | $7M | $7M | $6M |
| Total equity | $10M | $13M | $11M | $12M | $9M | $8M | $723,959 | $2M |
Implied volatility — last 90 days
Sector peers
ABVC earnings FAQ
When is ABVC's next earnings date?
ABVC Biopharma, Inc. is expected to report on October 30, 2026.
What is ABVC's expected move for earnings?
Options currently price a move of about ±476.6%, or $5.05 per share either way from $1.06.
How does ABVC stock usually react to earnings?
Across the last 4 reports the average next-day move was ±3.2%, up 2 times and down 2 times.
What is ABVC's implied volatility?
ABVC's at-the-money implied volatility is about 28% based on the latest options snapshot.